Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics

Stimcell Energetics Inc.

Reverse split 1:15 effective Nov 1, 2024; shares outstanding reduced from ~297M to ~19.8M.
Authorized capital reduced from 7.5B to 500M shares of common, par value $0.001.
Name changed from Cell MedX Corp. to Stimcell Energetics Inc.
Symbol will trade as "CMXCD" for 20 business days starting Nov 5, then seek new symbol.
New website launched at www.StimCell.com for investor and clinical trial info.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.